Role of adenosine signaling in penile erection and erectile disorders

Journal of Sexual Medicine

Volumn 7, Issue 11, 2010, Pages 3553-3564

  Phatarpekar, Prasad V ^a   Wen, Jiaming ^a   Xia, Yang ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Adenosine; Adenosine Receptor; Erectile Disorders; Erectile Dysfunction; Penile Erection and Erectile Physiology; Priapism

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR; MACROGOL;

ABSENCE OF SIDE EFFECTS; ARTICLE; DRUG MEGADOSE; ERECTILE DYSFUNCTION; HUMAN; NEUROMODULATION; NONHUMAN; ORGANIC IMPOTENCE; PATHOPHYSIOLOGY; PENIS ERECTION; PRIAPISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE RELAXATION; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 78049461249     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2009.01555.x     Document Type: Review

References (71)

1. Burnett AL. Neurophysiology of erectile function: Androgenic effects. J Androl 2003;24:S2-5.
2. Burnett AL. Nitric oxide in the penis: Physiology and pathology. J Urol 1997;157:320-4.
3. Andersson KE. Pharmacology of penile erection. Pharmacol Rev 2001;53:417-50.
4. Wu HY, Broderick GA, Suh JK, Hypolite JA, Levin RM. Effects of purines on rabbit corpus cavernosum contractile activity. Int J Impot Res 1993;5:161-7.
5. Levin RM, Hypolite J, Broderick GA. Comparative studies on rabbit corpus cavernosal contraction and relaxation. An in vitro study. J Androl 1994;15:36-40.
6. Mantelli L, Amerini S, Ledda F, Forti G, Maggi M. The potent relaxant effect of adenosine in rabbit corpora cavernosa is nitric oxide independent and mediated by A2 receptors. J Androl 1995;16:312-7.
7. Filippi S, Mancini M, Amerini S, Bartolini M, Natali A, Mancina R, Forti G, Ledda F, Maggi M. Functional adenosine receptors in human corpora cavernosa. Int J Androl 2000;23:210-7.
8. Tostes RC, Giachini FR, Carneiro FS, Leite R, Inscho EW, Webb RC. Determination of adenosine effects and adenosine receptors in murine corpus cavernosum. J Pharmacol Exp Ther 2007;322:678-85.
9. Mi T, Abbasi S, Zhang H, Uray K, Chunn JL, Xia LW, Molina JG, Weisbrodt NW, Kellems RE, Blackburn MR, Xia Y. Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling. J Clin Invest 2008;118:1491-501.
10. Dahm P, Rao DS, Donatucci CF. Antiandrogens in the treatment of priapism. Urology 2002;59:138.
11. Andersson KE, Wagner G. Physiology of penile erection. Physiol Rev 1995;75:191-236.
12. Prieto D. Physiological regulation of penile arteries and veins. Int J Impot Res 2008;20:17-29.
13. Simonsen U, Garcia-Sacristan A, Prieto D. Penile arteries and erection. J Vasc Res 2002;39:283-303.
14. Christ GJ, Richards S, Winkler A. Integrative erectile biology: The role of signal transduction and cell-to-cell communication in coordinating corporal smooth muscle tone and penile erection. Int J Impot Res 1997;9:69-84.
15. Kun A, Kiraly I, Pataricza J, Marton Z, Krassoi I, Varro A, Simonsen U, Papp JG, Pajor L. C-type natriuretic peptide hyperpolarizes and relaxes human penile resistance arteries. J Sex Med 2008;5:1114-25.
16. Lin CS. Phosphodiesterase type 5 regulation in the penile corpora cavernosa. J Sex Med 2009;6(3 suppl):203-9.
17. Lue TF. Erectile dysfunction. N Engl J Med 2000;342:1802-13.
18. Srilatha B, Adaikan PG, Li L, Moore PK. Hydrogen sulphide: A novel endogenous gasotransmitter facilitates erectile function. J Sex Med 2007;4:1304-11.
19. Fredholm BB, AP IJ, Jacobson KA, Klotz KN, Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 2001;53:527-52.
20. Fredholm BB. Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ 2007;14:1315-23.
21. Colgan SP, Eltzschig HK, Eckle T, Thompson LF. Physiological roles for ecto-5'-nucleotidase (CD73). Purinergic Signal 2006;2:351-60.
22. Kataoka K, Furukawa K, Nagao K, Ishii N, Tsuru H. The participation of adenosine receptors in the adenosine 5'-triphosphate-induced relaxation in the isolated rabbit corpus cavernosum penis. Int J Urol 2007;14:764-8.
23. Ragazzi E, Chinellato A, Italiano G, Pagano F, Calabro A. Characterization of in vitro relaxant mechanisms in erectile tissue from rabbits of different ages. Urol Res 1996;24:317-22.
24. Chiang PH, Wu SN, Tsai EM, Wu CC, Shen MR, Huang CH, Chiang CP. Adenosine modulation of neurotransmission in penile erection. Br J Clin Pharmacol 1994;38:357-62.
25. Takahashi Y, Ishii N, Lue TF, Tanagho EA. Pharmacological effects of adenosine on canine penile erection. Tohoku J Exp Med 1991;165:49-58.
26. Takahashi Y, Ishii N, Lue TF, Tanagho EA. Effects of adenosine on canine penile erection. J Urol 1992;148:1323-5.
27. Noto T, Inoue H, Mochida H, Kikkawa K. Role of adenosine and P2 receptors in the penile tumescence in anesthetized dogs. Eur J Pharmacol 2001;425:51-5.
28. Faria M, Magalhaes-Cardoso T, Lafuente-de-Carvalho JM, Correia-de-Sa P. Corpus cavernosum from men with vasculogenic impotence is partially resistant to adenosine relaxation due to endothelial A(2B) receptor dysfunction. J Pharmacol Exp Ther 2006;319:405-13.
29. Filippi S, Amerini S, Maggi M, Natali A, Ledda F. Studies on the mechanisms involved in the ATP-induced relaxation in human and rabbit corpus cavernosum. J Urol 1999;161:326-31.
30. Tager AM, LaCamera P, Shea BS, Campanella GS, Selman M, Zhao Z, Polosukhin V, Wain J, Karimi-Shah BA, Kim ND, Hart WK, Pardo A, Blackwell TS, Xu Y, Chun J, Luster AD. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat Med 2008;14:45-54.
31. Sebastiao AM, Ribeiro JA. Fine-tuning neuromodulation by adenosine. Trends Pharmacol Sci 2000;21:341-6.
32. Rongen GA, Lenders JW, Lambrou J, Willemsen JJ, Van Belle H, Thien T, Smits P. Presynaptic inhibition of norepinephrine release from sympathetic nerve endings by endogenous adenosine. Hypertension 1996;27:933-8.
33. Burnstock G. Historical review: ATP as a neurotransmitter. Trends Pharmacol Sci 2006;27:166-76.
34. Olsson RA, Pearson JD. Cardiovascular purinoceptors. Physiol Rev 1990;70:761-845.
35. Lin CS, Lin G, Lue TF. Cyclic nucleotide signaling in cavernous smooth muscle. J Sex Med 2005;2:478-91.
36. Mills TM, Lewis RW, Wingard CJ, Linder AE, Jin L, Webb RC. Vasoconstriction, RhoA/Rho-kinase and the erectile response. Int J Impot Res 2003;15(5 suppl):S20-4.
37. Smits P, Williams SB, Lipson DE, Banitt P, Rongen GA, Creager MA. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans. Circulation 1995;92:2135-41.
38. Ansari HR, Nadeem A, Talukder MA, Sakhalkar S, Mustafa SJ. Evidence for the involvement of nitric oxide in A2B receptor-mediated vasorelaxation of mouse aorta. Am J Physiol 2007;292:H719-25.
39. Gao F, Christopher TA, Lopez BL, Friedman E, Cai G, Ma XL. Mechanism of decreased adenosine protection in reperfusion injury of aging rats. Am J Physiol 2000;279:H329-38.
40. Vials A, Burnstock G. A2-purinoceptor-mediated relaxation in the guinea-pig coronary vasculature: A role for nitric oxide. Br J Pharmacol 1993;109:424-9.
41. Sobrevia L, Yudilevich DL, Mann GE. Activation of A2-purinoceptors by adenosine stimulates L-arginine transport (system y+) and nitric oxide synthesis in human fetal endothelial cells. J Physiol 1997;499:135-40.
42. Li J, Fenton RA, Wheeler HB, Powell CC, Peyton BD, Cutler BS, Dobson JG Jr. Adenosine A2a receptors increase arterial endothelial cell nitric oxide. J Surg Res 1998;80:357-64.
43. Wyatt AW, Steinert JR, Wheeler-Jones CP, Morgan AJ, Sugden D, Pearson JD, Sobrevia L, Mann GE. Early activation of the p42/p44MAPK pathway mediates adenosine-induced nitric oxide production in human endothelial cells: A novel calcium-insensitive mechanism. FASEB J 2002;16:1584-94.
44. Benson GE. Penile erection: In search of a neurotransmitter. World J Urol 1983;1:209-12.
45. Ignarro LJ, Bush PA, Buga GM, Wood KS, Fukuto JM, Rajfer J. Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Commun 1990;170:843-50.
46. Burnstock G. Purinergic nerves. Pharmacol Rev 1972;24:509-81.
47. Burnstock G, Kennedy C. Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol 1985;16:433-40.
48. Uchiyama T, Furukawa K. Adenosine 5'-triphosphate (ATP) purinoceptor is classical P2Y1 subtype in the rabbit corpus cavernosum penis. Jpn J Impot Res 2003;18:295-305.
49. Furukawa K, Uchiyama T. Analysis of adenosine 5'-triphosphate (ATP)-and adenosine 5'-diphosphate (ADP) -induced relaxations in isolated rabbit corpus cavernosum penis. Jpn J Impot Res 2004;19:225-35.
50. Tong YC, Broderick G, Hypolite J, Levin RM. Correlations of purinergic, cholinergic and adrenergic functions in rabbit corporal cavernosal tissue. Pharmacology 1992;45:241-9.
51. Takahashi Y, Ishii N, Lue TF, Tanagho EA. Effects of adenosine triphosphate on canine penile erection. Int J Impot Res 1992;4:27-34.
52. Calvert RC, Khan MA, Thompson CS, Mikhailidis DP, Burnstock G. A functional study of purinergic signalling in the normal and pathological rabbit corpus cavernosum. BJU Int 2008;101:1043-7.
53. Chinellato A, Ragazzi E, Petrelli L, Paro M, Mironov A, Aliev G. Effect of cholesterol-supplemented diet in heritable hyperlipidemic Yoshida rats: Functional and morphological characterization of thoracic aorta. Atherosclerosis 1994;106:51-63.
54. Ralevic V, Burnstock G. Actions mediated by P2-purinoceptor subtypes in the isolated perfused mesenteric bed of the rat. Br J Pharmacol 1988;95:637-45.
55. Ayan S, Yildirim S, Ucar C, Sarioglu Y, Gultekin Y, Butuner C. Corporal reactivity to adenosine and prostaglandin E1 in alloxan-induced diabetic rabbit corpus cavernosum, and the effect of insulin therapy. BJU Int 1999;83:108-12.
56. Gur S, Ozturk B. Altered relaxant responses to adenosine and adenosine 5'-triphosphate in the corpus cavernosum from men and rats with diabetes. Pharmacology 2000;60:105-12.
57. Carneiro FS, Giachini FR, Lima VV, Carneiro ZN, Leite R, Inscho EW, Tostes RC, Webb RC. Adenosine actions are preserved in corpus cavernosum from obese and type II diabetic db/db mouse. J Sex Med 2008;5:1156-66.
58. Kilicarslan H, Yildirim S, Bagcivan I, Ayan S, Sarac B, Sarioglu Y. Effect of chronic renal failure on the purinergic responses of corpus cavernosal smooth muscle in rabbits. BJU Int 2002;90:596-600.
59. Kilic S, Salih M, Anafarta K, Baltaci S, Kosar A. Adenosine: A new agent in the diagnosis of impotence. Int J Impot Res 1994;6:191-8.
60. Yildirim MK, Bagcivan I, Sarac B, Kilicarslan H, Yildirim S, Kaya T. Effect of hypothyroidism on the purinergic responses of corpus cavernosal smooth muscle in rabbits. Int Urol Nephrol 2008;40:691-9.
61. Dai Y, Zhang Y, Phatarpekar P, Mi T, Zhang H, Blackburn MR, Xia Y. Adenosine signaling, priapism and novel therapies. J Sex Med 2009;6(3 suppl):292-301.
62. Kaya T, Sarioglu Y, Goksu OC, Yildirim S, Yildirim K. Effect of additional testosterone on purinergic responses in isolated rabbit corpus cavernosum strips. Pharmacol Res 1998;37:227-32.
63. Lerman BB, Belardinelli L. Cardiac electrophysiology of adenosine. Basic and clinical concepts. Circulation 1991;83:1499-509.
64. Burnett AL. Priapism pathophysiology: Clues to prevention. Int J Impot Res 2003;15(5 suppl):S80-5.
65. Burnett AL. Pathophysiology of priapism: Dysregulatory erection physiology thesis. J Urol 2003;170:26-34.
66. Bivalacqua TJ, Musicki B, Hsu LL, Gladwin MT, Burnett AL, Champion HC. Establishment of a transgenic sickle-cell mouse model to study the pathophysiology of priapism. J Sex Med 2009;6:2494-504.
67. Champion HC, Bivalacqua TJ, Takimoto E, Kass DA, Burnett AL. Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proc Natl Acad Sci USA 2005;102:1661-6.
68. Claudino MA, Franco-Penteado CF, Corat MA, Gimenes AP, Passos LA, Antunes E, Costa FF. Increased cavernosal relaxations in sickle cell mice priapism are associated with alterations in the NO-cGMP signaling pathway. J Sex Med 2009;6:2187-96.
69. Burnett AL, Bivalacqua TJ. Priapism: Current principles and practice. Urol Clin North Am 2007;34:631-42, viii.
70. Hershfield MS. PEG-ADA replacement therapy for adenosine deaminase deficiency: An update after 8.5 years. Clin Immunol Immunopathol 1995;76:S228-32.
71. Blackburn MR, Kellems RE. Adenosine deaminase deficiency: Metabolic basis of immune deficiency and pulmonary inflammation. Adv Immunol 2005;86:1-41.